Table 4 Characteristics of the studies about children PFUI
Researcher | Year | Country | Follow-up (months) | Sample Size | Outcomes: PR vs. SCDU | Recommended operation |
|---|---|---|---|---|---|---|
Avanoglu | 1996 | Turkey | 6-144 | 18 | US:7/14(50%) vs. 2/4(50%) UI:4/14(28.6%) vs. 2/4(50%) | PR |
Qu | 2014 | China | 3–12 | 177 | US:2/35(5.7%) vs. 17/142(12%) NP:1.1 vs. 2.6 ED:3/35(8.6%) vs. 31/142(21.8%) UI:4/35(11.4%) vs. 25/142(17.6%) | PR |
Nerli | 2008 | India | 25–132 | 22 | US:5/12(41.7%) vs. 5/10(50%) UC:0/12(0%) vs. 1/10(10%) UI:0/12(0%) vs. 0/10(0%) | PR |
Taha | 2023 | Egypt | NA | 40 | NP:3.5 vs. 2 UI:4/20(20%) vs. 6/20(30%) | SCDU |
Balkan | 2005 | Turkey | 4–5 | 20 | US:2/12(16.6%) vs. 3/8(37.5%) UI:1/12(8.3%) vs. 1/8(12.5%) | PR |
Podesta | 2015 | Argentina | 78 | 49 | ED:1/14(7.1%) vs. 2/35(5.7%) UI:4/14(28.6%) vs. 5/35(14.3%) | PR |
Onen | 2005 | Turkey | 48–204 | 38 | US:5/22(22.7%) vs. 4/16(25%) ED:5/22(22.7%) vs. 3/16(18.8%) UI:4/22(18.2%) vs. 3/16(18.8%) | PR |